Search
for
Sort by
Research 331–360 of 1000+
- Low-level light therapy and hair loss
- Androgenetic alopecia (male pattern hair loss) in the United States: What treatments should primary care providers recommend?
- Surgical hair restoration
- Current Cosmetic Treatments in Pregnancy
- Pregnancy and neonatal outcome with maternal exposure to finasteride: Case series
- Dermatologia e Procedimentos Estéticos Ed. XVIII
- The Possible Role of Prescribing Medications, Including Central Nervous System Drugs, in Contributing to Male-Factor Infertility (MFI): Assessment of the Food and Drug Administration (FDA) Pharmacovigilance Database
- Case report: A pregnant woman accidental treated with spironolactone in mid-gestation
- A Gender Hypothesis of sex disparities in adverse drug events
- Mercury rising
- Androgenetic Alopecia: An Update of Treatment Options
- What to Look for in Red Light Therapy: A Product Guide Backed by Science
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Research progress in the treatment of non-scarring alopecia: mechanism and treatment
- Endocrine disorders and hormonal therapy for adolescent acne
- Androgens and acne: perspectives on clascoterone, the first topical androgen receptor antagonist
- Physiology and Medical Treatments for Alopecia
- Efficacy and Safety of Spironolactone in Acne Management
- Polycystic ovarian syndrome
- Hormonal Therapies for Acne: A Comprehensive Update for Dermatologists
- Therapeutic potential of bimatoprost for the treatment of eyebrow hypotrichosis
- Real-world study of adverse events associated with gepant use in migraine treatment based on the VigiAccess and U.S. Food and Drug Administration’s adverse event reporting system databases
- An Update on Hair Restoration
- Telogen Effluvium: A Review
- Teriflunomide (Aubagio®) for the treatment of multiple sclerosis
- Contraception and the dermatologist
- The Hirsute Woman: Challenges in Evaluation and Management
- ADVANCES IN PSORIASIS THERAPY
- Teriflunomide: a novel oral treatment for relapsing multiple sclerosis
- Androgenetic alopecia – Current status